Gerbing RB - Search Results

1

Genomic Variants of Cytarabine Sensitivity Associated with Treatment-Related Mortality in Pediatric AML: A Report from the Children's Oncology Group.

Phillips CL, Lane A, Gerbing RB, Alonzo TA, Wilkey A, Radloff G, Lange B, Gamazon ER, Dolan ME, Davies SM. Phillips CL, et al. Among authors: gerbing rb. Clin Cancer Res. 2020 Jun 15;26(12):2891-2897. doi: 10.1158/1078-0432.CCR-19-3117. Epub 2020 Mar 2. Clin Cancer Res. 2020. PMID: 32122921 Free PMC article.

2

Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study.

Perez CA, Matthay KK, Atkinson JB, Seeger RC, Shimada H, Haase GM, Stram DO, Gerbing RB, Lukens JN. Perez CA, et al. Among authors: gerbing rb. J Clin Oncol. 2000 Jan;18(1):18-26. doi: 10.1200/JCO.2000.18.1.18. J Clin Oncol. 2000. PMID: 10623689 Clinical Trial.

3

Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.

Maris JM, Weiss MJ, Guo C, Gerbing RB, Stram DO, White PS, Hogarty MD, Sulman EP, Thompson PM, Lukens JN, Matthay KK, Seeger RC, Brodeur GM. Maris JM, et al. Among authors: gerbing rb. J Clin Oncol. 2000 May;18(9):1888-99. doi: 10.1200/JCO.2000.18.9.1888. J Clin Oncol. 2000. PMID: 10784629

4

Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia.

Sievers EL, Lange BJ, Alonzo TA, Gerbing RB, Bernstein ID, Smith FO, Arceci RJ, Woods WG, Loken MR. Sievers EL, et al. Among authors: gerbing rb. Blood. 2003 May 1;101(9):3398-406. doi: 10.1182/blood-2002-10-3064. Epub 2002 Dec 27. Blood. 2003. PMID: 12506020 Free article.

5

Pilot study of idarubicin-based intensive-timing induction therapy for children with previously untreated acute myeloid leukemia: Children's Cancer Group Study 2941.

Lange BJ, Dinndorf P, Smith FO, Arndt C, Barnard D, Feig S, Feusner J, Seibel N, Weiman M, Aplenc R, Gerbing R, Alonzo TA. Lange BJ, et al. J Clin Oncol. 2004 Jan 1;22(1):150-6. doi: 10.1200/JCO.2004.04.016. J Clin Oncol. 2004. PMID: 14701777 Clinical Trial.

6

Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition.

Brown P, Meshinchi S, Levis M, Alonzo TA, Gerbing R, Lange B, Arceci R, Small D. Brown P, et al. Blood. 2004 Sep 15;104(6):1841-9. doi: 10.1182/blood-2004-03-1034. Epub 2004 May 27. Blood. 2004. PMID: 15166029 Free article.

7

Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia.

Tse W, Meshinchi S, Alonzo TA, Stirewalt DL, Gerbing RB, Woods WG, Appelbaum FR, Radich JP. Tse W, et al. Among authors: gerbing rb. Blood. 2004 Nov 15;104(10):3058-63. doi: 10.1182/blood-2003-12-4347. Epub 2004 Jun 24. Blood. 2004. PMID: 15217837 Free article. Clinical Trial.

8

PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group.

Loh ML, Reynolds MG, Vattikuti S, Gerbing RB, Alonzo TA, Carlson E, Cheng JW, Lee CM, Lange BJ, Meshinchi S; Children's Cancer Group. Loh ML, et al. Among authors: gerbing rb. Leukemia. 2004 Nov;18(11):1831-4. doi: 10.1038/sj.leu.2403492. Leukemia. 2004. PMID: 15385933

9

Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.

Kobayashi C, Monforte-Munoz HL, Gerbing RB, Stram DO, Matthay KK, Lukens JN, Seeger RC, Shimada H. Kobayashi C, et al. Among authors: gerbing rb. Cancer. 2005 Jan 1;103(1):174-80. doi: 10.1002/cncr.20717. Cancer. 2005. PMID: 15549714 Free article.

10

Mortality in overweight and underweight children with acute myeloid leukemia.

Lange BJ, Gerbing RB, Feusner J, Skolnik J, Sacks N, Smith FO, Alonzo TA. Lange BJ, et al. Among authors: gerbing rb. JAMA. 2005 Jan 12;293(2):203-11. doi: 10.1001/jama.293.2.203. JAMA. 2005. PMID: 15644547 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page